The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

PURPOSE: The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now commercially available in the U.S., Europe and Australia. We investigate whether phi improves specificity for detecting clinically significa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Urol
Autores principales: Loeb, Stacy, Sanda, Martin G., Broyles, Dennis L., Shin, Sanghyuk S., Bangma, Chris H., Wei, John T., Partin, Alan W., Klee, George G., Slawin, Kevin M., Marks, Leonard S., van Schaik, Ron H. N., Chan, Daniel W., Sokoll, Lori J., Cruz, Amabelle B., Mizrahi, Isaac A., Catalona, William J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404198/
https://ncbi.nlm.nih.gov/pubmed/25463993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.10.121
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares